Heat Biologics, Inc. (HTBX) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $2.12, down from yesterday’s close by -18.46%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.Fundamental Analysis
Heat Biologics, Inc. (HTBX) currently trades with a market capitalization of $12.30 Million. That value represents a market adjusting for revenues that have been growing by 3,004.50 % on a quarterly year/year basis as of the company’s last quarterly report.
You can get a sense of how sustainable that is by a levered free cash flow of -$7.62 Million over the past twelve months. Generally speaking, earnings are expected to hold steady in coming quarters. Analysts are forecasting earnings of $0 on a per share basis this quarter. Perhaps, that suggests something about why 5.67% of the outstanding share supply is held by institutional investors.
We’ve taken a serious look at this stock from a fundamental perspective, but the tale of the tape may offer more hints about what lies under the surface. Looking at the stock’s movement on the chart, Heat Biologics, Inc. recorded a 52-week high of $7.89. It is now trading 5.77% off that level. The stock is trading $1.74 its 50-day moving average by -0.38%. The stock carved out a 52-week low down at $1.09.
In recent action, Heat Biologics, Inc. (HTBX) has made a move of +46.21% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 14.11, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 15.30% with $5.43 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of HTBX.